{"id":"W2947616753","doi":"10.1136/annrheumdis-2019-eular.2886","title":"OP0029 SWITCHING BETWEEN THE JAK1-SELECTIVE INHIBITOR-UPADACITINIB AND ADALIMUMAB FOLLOWING INITIAL NON-RESPONSE: CLINICAL AND FUNCTIONAL OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Research Manitoba","funders":"Sanofi Genzyme; Genentech; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Methotrexate; Placebo; Adverse effect; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001286968,0.0002852429,0.0008386879,0.0001140168,0.0003007913,0.00008440042,0.0002307548,0.0001239438,0.00005325456],"category_scores_gemma":[0.003905215,0.0001690207,0.0004261451,0.0002288439,0.0005047826,0.0002775038,0.0004344762,0.0003538049,0.00001782336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001944852,"about_ca_system_score_gemma":0.001522835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002488603,"about_ca_topic_score_gemma":0.00001516094,"domain_scores_codex":[0.9966757,0.0005142383,0.0009005504,0.0004238944,0.00104313,0.0004424396],"domain_scores_gemma":[0.9943879,0.004186846,0.0003310693,0.0005799851,0.0002157872,0.0002983777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001216886,0.0002001649,0.9756362,0.0001758093,0.0007370666,0.000006144974,0.0004662671,0.000005560438,0.000008322258,0.0000230485,0.00111723,0.02040728],"study_design_scores_gemma":[0.01378875,0.0003478947,0.9818414,0.001828536,0.0001153812,0.00001263392,0.0004164214,0.0007037307,0.0001525469,0.0005672902,0.00004103563,0.0001843897],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996447,0.0008002589,0.00001589821,0.001036949,0.0003244125,0.001141726,0.00006976882,0.00002971611,0.0001342632],"genre_scores_gemma":[0.998964,0.0003924225,0.00001932698,0.0003551985,0.00006953431,0.00004266778,0.00002103478,0.00003990742,0.00009597323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02022289,"threshold_uncertainty_score":0.6892463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03605637087655619,"score_gpt":0.3478958673367878,"score_spread":0.3118394964602317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}